| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDRE | Stock Option (right to purchase) | Award | $0 | +117K | $0.00 | 117K | Mar 13, 2025 | Common Stock | 117K | $33.85 | Direct | F1, F3 | |
| transaction | CDRE | Restricted Stock Units | Award | $0 | +37.7K | $0.00 | 37.7K | Mar 13, 2025 | Common Stock | 37.7K | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The option to purchase 117,457 shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), was granted under the Plan. Options to purchase 39,153 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 39,152 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively. |
| F2 | Comprised of a restricted stock units award granted under the Plan consisting of 37,666 restricted shares of the Issuer's Common Stock. 12,556 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,555 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. |
| F3 | This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 6 and 7 have been renumbered and revised accordingly. |